EFFICACY AND SAFETY OF RIVAROXABAN FOR NON-VALVULAR ATRIAL FIBRILLATION IN PATIENTS WITH SEVERE RENAL IMPAIRMENT

被引：0
|
作者：
Ali, S. [1 ]
Wakefield, L. A. [1 ]
Saja, K. [1 ]
机构：
[1] Natl Hlth Serv, London, England
来源：
HAEMATOLOGICA | 2016年 / 101卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P409
引用
收藏
页码：140 / 140
页数：1
相关论文
共 50 条
  • [41] Effectiveness and Safety of Rivaroxaban by General Practitioners - A Multicenter, Prospective Study in Japanese Patients With Non-Valvular Atrial Fibrillation (GENERAL)
    Kusano, Kengo
    Sugishita, Nobuyoshi
    Akao, Masaharu
    Tsuji, Hikari
    Matsui, Kunihiko
    Hiramitsu, Shinya
    Hatori, Yutaka
    Odakura, Hironori
    Kamada, Hiroyuki
    Miyamoto, Koji
    Ogawa, Hisao
    CIRCULATION JOURNAL, 2021, 85 (08) : 1275 - +
  • [42] Effectiveness and safety of reduced-dose rivaroxaban for elderly patients with non-valvular atrial fibrillation: A subanalysis of the EXPAND study
    Shimizu, Wataru
    Uchiyama, Shinichiro
    Atarashi, Hirotsugu
    Inoue, Hiroshi
    Kitazono, Takanari
    Yamashita, Takeshi
    Ikeda, Takanori
    Kamouchi, Masahiro
    Kaikita, Koichi
    Fukuda, Koji
    Origasa, Hideki
    Shimokawa, Hiroaki
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2023, 391
  • [43] Rationale and design of the efficacy of rivaroxaban on renal function in patients with non-valvular atrial fibrillation and chronic kidney disease: The X-NOAC study
    Suzuki, Makoto
    Fukamizu, Seiji
    Oyama, Jun-ichi
    Mizukami, Akira
    Matsumura, Akihiko
    Hashimoto, Yuji
    Node, Koichi
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2015, 188 : 52 - 53
  • [44] Effectiveness and safety of rivaroxaban vs. warfarin in patients with non-valvular atrial fibrillation and coronary or peripheral artery disease
    Coleman, Craig, I
    Baker, William L.
    Meinecke, Anna-Katharina
    Eriksson, Daniel
    Martinez, Brandon K.
    Bunz, Thomas J.
    Alberts, Mark J.
    EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY, 2020, 6 (03) : 159 - 166
  • [45] Effectiveness and safety of rivaroxaban vs. warfarin in patients 80+ years of age with non-valvular atrial fibrillation
    Coleman, Craig I.
    Weeda, Erin R.
    Elaine Nguyen
    Bunz, Thomas J.
    Sood, Nitesh A.
    EUROPEAN HEART JOURNAL-QUALITY OF CARE AND CLINICAL OUTCOMES, 2018, 4 (04) : 328 - 329
  • [46] Rivaroxaban versus apixaban in non-valvular atrial fibrillation patients with end-stage renal disease or receiving dialysis
    Miao, Benjamin
    Sood, Nitesh
    Bunz, Thomas J.
    Coleman, Craig, I
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2020, 104 (04) : 328 - 335
  • [47] Population Pharmacokinetics of Rivaroxaban in Chinese Patients with Non-Valvular Atrial Fibrillation: A Prospective Multicenter Study
    Zhang, Feilong
    Chen, Xuehai
    Wu, Tingting
    Huang, Nianxu
    Li, Li
    Yuan, Dongdong
    Xiang, Jing
    Wang, Na
    Chen, Wenjun
    Zhang, Jinhua
    CLINICAL PHARMACOKINETICS, 2022, 61 (06) : 881 - 893
  • [48] Comparative effectiveness of rivaroxaban versus a vitamin K antagonist in patients with renal impairment treated for non-valvular atrial fibrillation in Germany - A retrospective cohort study
    Bonnemeier, Hendrik
    Huelsebeck, Maria
    Kloss, Sebastian
    IJC HEART & VASCULATURE, 2019, 23
  • [49] Persistent or permanent atrial fibrillation is associated with severe cardioembolic stroke in patients with non-valvular atrial fibrillation
    Hagii, Joji
    Metoki, Norifumi
    Saito, Shin
    Shiroto, Hiroshi
    Sasaki, Satoko
    Takahashi, Koki
    Hitomi, Hiroyasu
    Baba, Yoshiko
    Yamada, Natsumi
    Seino, Satoshi
    Kamada, Takaatsu
    Uchizawa, Takamitsu
    Nakamura, Taigen
    Yasujima, Minoru
    Tomita, Hirofumi
    THROMBOSIS JOURNAL, 2021, 19 (01)
  • [50] Persistent or permanent atrial fibrillation is associated with severe cardioembolic stroke in patients with non-valvular atrial fibrillation
    Joji Hagii
    Norifumi Metoki
    Shin Saito
    Hiroshi Shiroto
    Satoko Sasaki
    Koki Takahashi
    Hiroyasu Hitomi
    Yoshiko Baba
    Natsumi Yamada
    Satoshi Seino
    Takaatsu Kamada
    Takamitsu Uchizawa
    Taigen Nakamura
    Minoru Yasujima
    Hirofumi Tomita
    Thrombosis Journal, 19
12345